Work

177Lu-FAP-2286 Combined Chemotherapy in a Case of Thymus Nonkeratinizing Squamous Carcinoma With Superior Vena Cava Syndrome

Year: 2026

Type: article

Abstract: We reported a 52-year-old man with thymus nonkeratinized squamous carcinoma presenting with acute superior vena cava syndrome (SVCS) who received 177 Lu-FAP-2286 treatment and followed by low-dose chemotherapy. 68 Ga-FAP-2286 PET/CT revealed significantly less intensity of the mediastinal mass comparing to pretherapy scan, as well as significant relief of SVCS. No adverse effects were observed.

Source: Clinical Nuclear Medicine

DOI: 10.1097/rlu.0000000000006350

Authors: Jia Deng, Yingwei Wang, Tingting Xu, Yue Chen

Institutions: Southwest Medical University, Affiliated Hospital of Southwest Medical University

Language: English

Topic: Peptidase Inhibition and Analysis

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Department of Science and Technology of Sichuan Province, Southwest Medical University, Affiliated Hospital of Southwest Medical University